Product Program year 2021 Source: CMS Open Payments

Xience Sierra Coronary Stent System

Device Vascular

PDI 8717648227547

Open in the dashboard

General payments

$4,216

180 payments

Research payments

$0

0 payments

Through program year 2021, $4,216 in general payments and $0 in research payments were reported against Xience Sierra Coronary Stent System (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2021 General $4,216 180

Breakdown

Who paid General payments · program year 2021
  1. Abbott Laboratories $4,216 180 payments
Top recipients General payments · program year 2021
  1. David Zagha Cardiovascular Disease · Shrewsbury, NJ $395 9% · 28 payments
  2. Michael Happes Smithtown, NY $393 9% · 11 payments
  3. Ziad Abbud Ocean, NJ $391 9% · 27 payments
  4. Muhammad Shahid Cardiovascular Disease · Neptune, NJ $391 9% · 27 payments
  5. Konstantinos Voudris Interventional Cardiology · Minneapolis, MN $297 7% · 2 payments

The top 5 of 43 recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Cardiovascular Disease Internal Medicine $1,415 45% · 9 practitioners
  2. Interventional Cardiology Internal Medicine $1,221 39% · 17 practitioners
  3. Internal Medicine $344 11% · 4 practitioners
  4. Anesthesiology $79 2% · 1 practitioner
  5. Advanced Heart Failure and Transplant Cardiology Internal Medicine $58 2% · 1 practitioner

The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. New York $1,241 29% · 10 recipients
  2. New Jersey $1,177 28% · 3 recipients
  3. Ohio $694 16% · 6 recipients
  4. Pennsylvania $319 8% · 6 recipients
  5. California $166 4% · 1 recipient

The top 5 of 15 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

180 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record